Top

Osteoporosis International

Published in:

01-08-2016 | Original Article

25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese

Authors: V. Camozzi, A. C. Frigo, M. Zaninotto, F. Sanguin, M. Plebani, M. Boscaro, L. Schiavon, G. Luisetto

Published in: Osteoporosis International | Issue 8/2016

Abstract

Summary

After a single cholecalciferol load, peak serum 25-hydroxycholecalciferol (25OHD) is lower in individuals with a higher body mass index (BMI), probably due to it being distributed in a greater volume. Its subsequent disappearance from the serum is slower the higher the individual’s BMI, probably due to the combination of a larger body volume and a slower release into the circulation of vitamin D stored in adipose tissue.

Introduction

The aim of the study is to examine 25-hydroxycholecalciferol (25OHD) response to a single oral load of cholecalciferol in the normal weight, overweight, and obese.

Methods

We considered 55 healthy women aged from 25 to 67 years (mean ± SD, 50.8 ± 9.5) with a BMI ranging from 18.7 to 42 kg/m² (mean ± SD, 27.1 ± 6.0). The sample was divided into three groups by BMI: 20 were normal weight (BMI ≤ 25 kg/m²), 21 overweight (25.1 ≤ BMI ≤ 29.9 kg/ m²), and 14 obese (BMI ≥ 30 kg/m²). Each subject was given 300,000 IU of cholecalciferol orally during lunch. A fasting blood test was obtained before cholecalciferol loading and then 7, 30, and 90 days afterwards to measure serum 25OHD, 1,25 dihydroxyvitamin D [1,25 (OH)₂D], parathyroid hormone (PTH), calcium (Ca), and phosphorus (P). Participants’ absolute fat mass was measured using dual energy X-ray absorptiometry (DEXA).

Results

The fat mass of the normal weight subjects was significantly lower than that of the overweight, which in turn was lower than that of the obese participants. Serum 25OHD levels increased significantly in all groups, peaking 1 week after the cholecalciferol load. Peak serum 25OHD levels were lower the higher the individuals’ BMI. After peaking, the 25OHD levels gradually decreased, following a significantly different trend in the three groups. The slope was similar for the overweight and obese, declining significantly more slowly than in the normal weight group. In the sample as a whole, there was a weakly significant negative correlation between fat mass and baseline 25OHD level, while this correlation became strongly significant at all time points after cholecalciferol loading.

Conclusions

The lower peak 25OHD levels seen in the obese and overweight is probably due to the cholecalciferol load being distributed in a larger body volume. The longer persistence of 25OHD in their serum could be due to both their larger body volume and a slower release into the circulation of the vitamin D stored in their adipose tissue.

Available only for authorised users

Höck AD (2014) Vitamin D3 deficiency results in dysfunctions of immunity with severe fatigue and depression in a variety of diseases. In Vivo 28(1):133–145PubMed

Lucas RM, Gorman S, Geldenhuys S, Hart PH (2014) Vitamin D and immunity. F1000 Prime Rep. 1;6:118

Zittermann A (2014) Vitamin D and cardiovascular disease. Anticancer Res 34(9):4641–4648PubMed

Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S (2013) Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169(4):R59–R69CrossRefPubMed

Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, Mezza T, Vieth R, Colao A, Pittas A (2014) Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol 171(3):R101–R110CrossRefPubMed

Shui I, Giovannucci E (2014) Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 810:33–51PubMed

Ordóñez Mena JM, Brenner H (2014) Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol 810:17–32PubMed

Sai AJ, Walters RW, Fang X, Gallagher JC (2011) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96(3):E436–E446CrossRefPubMed

Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424CrossRefPubMed

10.

Peterson CA, Tosh AK, Belenchia AM (2014) Vitamin D insufficiency and insulin resistance in obese adolescents. Ther Adv Endocrinol Metab 5(6):166–189CrossRefPubMedPubMedCentral

11.

Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S (2014) Vitamin D and its relationship with obesity and muscle. Int J Endocrinol 2014:841248. doi:10.1155/2014/841248 CrossRefPubMedPubMedCentral

12.

Gulseth HL, Gjelstad IM, Birkeland KI, Drevon CA (2013) Vitamin D and the metabolic syndrome. Curr Vasc Pharmacol 11(6):968–984CrossRefPubMed

13.

Vanlint S (2013) Vitamin D and obesity. Nutrients 5(3):949–956CrossRefPubMedPubMedCentral

14.

Blum M, Dallal GE, Dawson-Hughes B (2008) Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 27(2):274–279CrossRefPubMedPubMedCentral

15.

Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR (2009) Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 122(11):1056–1060CrossRefPubMed

16.

Tepper S, Shahar DR, Geva D, Ish-Shalom S (2014) Predictors of serum 25(OH)D increase following bimonthly supplementation with 100,000 IU vitamin D in healthy, men aged 25-65 years. J Steroid Biochem Mol Biol 144 Pt A:163–166CrossRefPubMed

17.

Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ (2014) The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One 9(11):e111265CrossRefPubMedPubMedCentral

18.

Montomoli M, Gonnelli S, Giacchi M, Mattei R, Cuda C, Rossi S, Gennari C (2002) Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr 56(1):21–30CrossRefPubMed

19.

Glanz K, Yaroch AL, Dancel M, Saraiya M, Crane LA, Buller DB, Manne S, O’Riordan DL, Heckman CJ, Hay J, Robinson JK (2008) Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol 144(2):217–222CrossRefPubMed

20.

Società Italiana dell’Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro (2013) Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society. Minerva Endocrinol 38(1 Suppl 1):1–30

21.

Saneei P, Salehi-Abargouei A, Esmaillzadeh A (2013) Serum 25-hydroxyvitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 14(5):393–404CrossRefPubMed

22.

Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688SPubMed

23.

Foo LH, Teo PS, Abdullah NF, Aziz ME, Hills AP (2013) Relationship between anthropometric and dual energy X-ray absorptiometry measures to assess total and regional adiposity in Malaysian adolescents. Asia Pac J Clin Nutr 22(3):348–356PubMed

24.

Drincic AT, Armas LA, Van Diest EE, Heaney RP (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20(7):1444–1448CrossRefPubMed

25.

Drincic A, Fuller E, Heaney RP, Armas LA (2013) 25-Hydroxyvitamin D response to graded vitamin D₃ supplementation among obese adults. J Clin Endocrinol Metab 98(12):4845–4851CrossRefPubMed

26.

Didriksen A, Burild A, Jakobsen J, Fuskevåg OM, Jorde R (2015) Vitamin D₃ increases in abdominal subcutaneous fat tissue after supplementation with vitamin D₃. Eur J Endocrinol 172(3):235–241CrossRefPubMed

27.

Brock K, Cant R, Clemson L, Mason RS, Fraser DR (2007) Effects of diet and exercise on plasma vitamin D (25OHD) levels in Vietnamese immigrant elderly in Sydney, Australia. J Steroid Biochem Mol Biol 103(3-5):786–792CrossRefPubMed

28.

Abboud M, Puglisi DA, Davies BN, Rybchyn M, Whitehead NP, Brock KE, Cole L, Gordon-Thomson C, Fraser DR, Mason RS (2013) Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 154(9):3022–3030CrossRefPubMed

29.

Rowling MJ, Kemmis CM, Taffany DA, Welsh J (2006) Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr 136(11):2754–2759PubMedPubMedCentral

30.

Abboud M, Gordon-Thomson C, Hoy AJ, Balaban S, Rybchyn MS, Cole L, Su Y, Brennan-Speranza TC, Fraser DR, Mason RS (2014) Uptake of 25-hydroxyvitamin D by muscle and fat cells. J Steroid Biochem Mol Biol 144 Pt A:232–236CrossRefPubMed

31.

Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (1993) Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91(6):2552–2555CrossRefPubMedPubMedCentral

32.

Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88(2):582S–586SPubMed

33.

Piccolo BD, Dolnikowski G, Seyoum E, Thomas AP, Gertz ER, Souza EC, Woodhouse LR, Newman JW, Keim NL, Adams SH, Van Loan MD (2013) Association between subcutaneous white adipose tissue and serum 25-hydroxyvitamin D in overweight and obese adults. Nutrients 5(9):3352–3366CrossRefPubMedPubMedCentral

34.

Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Neuhouser ML, Jeffery RW, Robien K, Alfano CM, Blackburn GL, McTiernan A (2011) Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94(1):95–103CrossRefPubMedPubMedCentral

35.

Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ (2011) 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70(4):654–659CrossRef

36.

Ritter CS, Brown AJ (2011) Direct suppression of PTH gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor. J Mol Endocrinol 46(2):63–66PubMed

37.

Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M (2011) Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 96(5):1320–1326CrossRefPubMedPubMedCentral

Title: 25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese
Authors: V. Camozzi
A. C. Frigo
M. Zaninotto
F. Sanguin
M. Plebani
M. Boscaro
L. Schiavon
G. Luisetto
Publication date: 01-08-2016
Publisher: Springer London
Published in: Osteoporosis International / Issue 8/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3574-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2016

Measuring muscle and bone in individuals with neurologic impairment; lessons learned about participant selection and pQCT scan acquisition and analysis

The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis

Variations in fat mass contribution to bone mineral density by gender, age, and body mass index: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008–2011

Full 24-month treatment course with daily teriparatide: a mechanistic insight

Quality of life, resource use, and costs related to hip fracture in Estonia

Current trends and future projections of hip fracture in South Korea using nationwide claims data